1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Animal Vaccine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Animal Vaccine Market Revenue and Volume Forecast, by Product Type
8.1.1. Attenuated Live Vaccines
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Inactivated Vaccines
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Subunit Vaccines
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. DNA Vaccines
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Recombinant Vaccines
8.1.5.1. Market Revenue and Volume Forecast
9.1. Animal Vaccine Market Revenue and Volume Forecast, by Animal Type
9.1.1. Livestock
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Companion
9.1.2.1. Market Revenue and Volume Forecast
10.1. Animal Vaccine Market Revenue and Volume Forecast, by Route of Administration
10.1.1. Subcutaneous
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Intramuscular
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Intranasal
10.1.3.1. Market Revenue and Volume Forecast
11.1. Animal Vaccine Market Revenue and Volume Forecast, by End User
11.1.1. Hospital
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. clinics
11.1.2.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type
12.1.2. Market Revenue and Volume Forecast, by Animal Type
12.1.3. Market Revenue and Volume Forecast, by Route of Administration
12.1.4. Market Revenue and Volume Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type
12.1.5.2. Market Revenue and Volume Forecast, by Animal Type
12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration
12.1.5.4. Market Revenue and Volume Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type
12.1.6.2. Market Revenue and Volume Forecast, by Animal Type
12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration
12.1.6.4. Market Revenue and Volume Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type
12.2.2. Market Revenue and Volume Forecast, by Animal Type
12.2.3. Market Revenue and Volume Forecast, by Route of Administration
12.2.4. Market Revenue and Volume Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type
12.2.5.2. Market Revenue and Volume Forecast, by Animal Type
12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration
12.2.5.4. Market Revenue and Volume Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type
12.2.6.2. Market Revenue and Volume Forecast, by Animal Type
12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration
12.2.6.4. Market Revenue and Volume Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type
12.2.7.2. Market Revenue and Volume Forecast, by Animal Type
12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration
12.2.7.4. Market Revenue and Volume Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type
12.2.8.2. Market Revenue and Volume Forecast, by Animal Type
12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration
12.2.8.4. Market Revenue and Volume Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type
12.3.2. Market Revenue and Volume Forecast, by Animal Type
12.3.3. Market Revenue and Volume Forecast, by Route of Administration
12.3.4. Market Revenue and Volume Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type
12.3.5.2. Market Revenue and Volume Forecast, by Animal Type
12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration
12.3.5.4. Market Revenue and Volume Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type
12.3.6.2. Market Revenue and Volume Forecast, by Animal Type
12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration
12.3.6.4. Market Revenue and Volume Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type
12.3.7.2. Market Revenue and Volume Forecast, by Animal Type
12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration
12.3.7.4. Market Revenue and Volume Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type
12.3.8.2. Market Revenue and Volume Forecast, by Animal Type
12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration
12.3.8.4. Market Revenue and Volume Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type
12.4.2. Market Revenue and Volume Forecast, by Animal Type
12.4.3. Market Revenue and Volume Forecast, by Route of Administration
12.4.4. Market Revenue and Volume Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type
12.4.5.2. Market Revenue and Volume Forecast, by Animal Type
12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration
12.4.5.4. Market Revenue and Volume Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type
12.4.6.2. Market Revenue and Volume Forecast, by Animal Type
12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration
12.4.6.4. Market Revenue and Volume Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type
12.4.7.2. Market Revenue and Volume Forecast, by Animal Type
12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration
12.4.7.4. Market Revenue and Volume Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type
12.4.8.2. Market Revenue and Volume Forecast, by Animal Type
12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration
12.4.8.4. Market Revenue and Volume Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.2. Market Revenue and Volume Forecast, by Animal Type
12.5.3. Market Revenue and Volume Forecast, by Route of Administration
12.5.4. Market Revenue and Volume Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type
12.5.5.2. Market Revenue and Volume Forecast, by Animal Type
12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration
12.5.5.4. Market Revenue and Volume Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type
12.5.6.2. Market Revenue and Volume Forecast, by Animal Type
12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration
12.5.6.4. Market Revenue and Volume Forecast, by End User
13.1. Merck & Co., Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Zoetis
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Boehringer Ingelheim International GmbH
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Virbac
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Biogénesis Bagó
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Indian Immunologicals Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Elanco
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ceva
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Phibro Animal Health Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Neogen Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
